5 employees
Flaskworks is improves the manufacture of immuno-therapeutics and dendritic cell-based vaccines.
2016
$200K
from 1 investors over 1 rounds
Flaskworks raised $200K on September 3, 2019
Investors: Massachusetts Life Sciences Center